Apr 21, 2023 Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation
Feb 27, 2023 Tonix signs agreement with UMB to use monoclonal antibodies in preventing heart transplant rejection
Jan 9, 2023 Seth Lederman, Co-Founder, CEO & Chairman of Tonix Pharmaceuticals discusses the state of Covid-19 in the U.S. and China
Oct 6, 2022 Tonix Pharmaceuticals says IND application for TNX-601 to treat depression is a major milestone
Aug 31, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Aug 16, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Aug 12, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by Bloomberg Radio
Jun 9, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
May 6, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Feb 11, 2022 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Dec 11, 2021 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Nov 17, 2021 Tonix begins work at its Infectious Disease R&D Center in Maryland, discusses RELIEF results
Oct 5, 2021 Interview with Dr. Seth Lederman, CEO of Tonix Pharmaceuticals (NASDAQ: TNXP), by journalist Jane King
Aug 23, 2021 Tonix Pharma CEO discusses Phase 3 RALLY study results and intent to acquire new R&D facility
